433 results
Page 4 of 22
8-K
EX-99.1
94o578zw16n0pl
13 Aug 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 Second Quarter Financial Results
4:08pm
8-K
EX-4.1
tgi71bct
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-10.2
78tq0cq9iuf3kjsn
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-10.1
k969fn
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
424B3
upw2e39
29 Jun 20
Prospectus supplement
12:00am
424B5
pmjq6kmnhghs9t61
26 May 20
Prospectus supplement for primary offering
4:02pm
8-K
EX-10.1
no0vpxv 1v
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-4.1
eyaqh8 m3yiy1m
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-99.1
nhbgg
7 May 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 First Quarter Financial Results
4:09pm
424B5
u7x065l3m f9t9
27 Apr 20
Prospectus supplement for primary offering
7:30am
8-K
EX-10.1
cxihm5ynmyez8l6kj
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm
8-K
EX-4.1
v1uwx2e
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm